Oncology Nurses as Patient Advocates

Article

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other members of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other memebers of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

In this month’s episode of the CURE Talks Cancer Podcast: Nursing Edition, Werner — an oncology nurse by trade – discusses how nurses can be the best advocates for their patients, how to navigate life in the era of “Dr. Google,” and more.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
mental health

Palliative Care Is Underutilized, May Boost Mental Health in Pancreatic Cancer

Gina Mauro
November 21st 2024
Article

Approximately one-third of patients with pancreatic cancer and anxiety had a palliative care consultation, data showed.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid Cancers

FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid Cancers

Chris Ryan
November 20th 2024
Article

The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

syringe in bottle

Subcutaneous Pembrolizumab Is Noninferior to IV Formulation in NSCLC

Ryan Scott
November 19th 2024
Article

Subcutaneous pembrolizumab plus chemotherapy was noninferior to IV pembrolizumab plus chemotherapy in treatment-naïve non-small cell lung cancer.

blood cells on blue background

Bendamustine-Obinutuzumab Combo May Improve CR Rates in MCL

Ashling Wahner
November 19th 2024
Article

Bendamustine plus obinutuzumab outperformed historical data of bendamustine plus rituximab for patients with treatment naïve mantle cell lymphoma.

© 2024 MJH Life Sciences

All rights reserved.